INTRODUÇÃOA colonoscopia é usualmente aceita como o exame de escolha para a detecção e tratamento de lesões do cólon. Contudo, sem um preparo adequado, pequenas tumorações podem ficar encobertas por fezes formadas, e não serem detectadas (AREZZO).Desta forma, uma das necessidades básicas para a realização da colonoscopia é um preparo adequado do cólon, possibilitando a realização do exame de forma segura, com introdução do aparelho sob visão direta e evitando deixar passar desapercebidas lesões colônicas. Entretanto, faz-se necessário que o preparo para a realização do exame seja aceitável para o paciente e efetivo na limpeza do cólon, além de ser de baixo custo (HABR-GAMA-1999, SAUNDERS, HUPPERTZ-HAUSS).Dentre os produtos existentes na literatura, o manitol e o polietilenoglicol são os mais utilizados, sendo ambos seguros e efetivos para a utilização no preparo do cólon para a colonoscopia (HABR-GAMA-1981, NAHAS, HABR-GAMA-1999. Mas, será que ambas as substâncias são realmente semelhantes?O objetivo deste estudo é comparar o preparo do cólon para colonoscopia, utilizando o manitol e o polietilenoglicol (PEG), levando-se em consideração a aceitação dos pacientes e a efetividade na limpeza do cólon.
MÉTODOForam estudados, prospectivamente e de forma consecutiva, 55 pacientes submetidos ao exame colonoscópico no Serviço de Coloproctologia do Hos-
393SILVA HLMA, BATISTA LVC, MOURA LDL, JÚNIOR LCVT, AROUCHA J, BELO SG, NETO MÁL. Indicação da anuscopia de alta resolução e citologia anal na prevenção de hpv e câncer colorretal em pacientes portadores de hiv. Rev bras Coloproct, 2011;30(4): 393-398.
Background: Vasculitis is an uncommon complication of biologics used to treat inflammatory bowel disease (IBD). This study describes a case series of vasculitis induced by anti-tumor necrosis factor (TNF) therapy in IBD patients. Methods: Retrospective assessments were performed using the medical records of adult IBD patients who underwent outpatient clinical follow-ups between January 2010 and December 2019 in order to identify patients with vasculitis caused by anti-TNF therapy. Results: There were 2442 patients altogether. Of these, 862 (35%) took anti-TNF medication. Five patients (0.6% of the overall patients; n = 3 (60%) Crohn’s disease; n = 2 (40%), ulcerative colitis) were identified as having leukocytoclastic vasculitis (LCV) due to anti-TNF therapy; these patients were white, female, and non-smokers. The mean age of LCV diagnosis was 32.2 years, and the mean IBD duration was 7.2 years. The mean time between the start of biologic therapy and LCV onset was 30.8 months. Most of the patients were using adalimumab (80%; n = 4). All the patients were in remission at the time of the LCV diagnosis, and the vasculitis affected the skin in all cases. Anti-TNF therapy was discontinued in the five abovementioned patients, and the response of LCV to the oral steroids was significantly positive. Remarkably, all five patients experienced complete remission from LCV within 4–12 weeks after starting prednisone therapy, and none of them had LCV recurrence in the follow-up period (a mean duration of 28 months). Conclusions: LCV is an unusual complication of anti-TNF therapy in the IBD setting. In this context, clinicians should have a high degree of suspicion of LCV in patients who develop an unexplained cutaneous rash.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.